HUP0004627A2 - Farnezil-protein transzferáz inhibitor hatású új triciklusos szulfonamidszármazékok és a vegyületeket tartalmazó gyógyszerkészítmények - Google Patents

Farnezil-protein transzferáz inhibitor hatású új triciklusos szulfonamidszármazékok és a vegyületeket tartalmazó gyógyszerkészítmények Download PDF

Info

Publication number
HUP0004627A2
HUP0004627A2 HU0004627A HUP0004627A HUP0004627A2 HU P0004627 A2 HUP0004627 A2 HU P0004627A2 HU 0004627 A HU0004627 A HU 0004627A HU P0004627 A HUP0004627 A HU P0004627A HU P0004627 A2 HUP0004627 A2 HU P0004627A2
Authority
HU
Hungary
Prior art keywords
group
compounds
alkyl
formula
heteroaryl
Prior art date
Application number
HU0004627A
Other languages
English (en)
Hungarian (hu)
Inventor
Ronald J. Doll
Viyyoor M. Girijavallabhan
F. George Njoroge
Arthur G. Taveras
Bancha Vibulbhan
Original Assignee
Schering Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp. filed Critical Schering Corp.
Publication of HUP0004627A2 publication Critical patent/HUP0004627A2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
HU0004627A 1997-06-17 1998-06-15 Farnezil-protein transzferáz inhibitor hatású új triciklusos szulfonamidszármazékok és a vegyületeket tartalmazó gyógyszerkészítmények HUP0004627A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87705097A 1997-06-17 1997-06-17
PCT/US1998/011508 WO1998057949A1 (fr) 1997-06-17 1998-06-15 Nouveaux sulfonamides tricycliques inhibiteurs de la farnesyle transferase

Publications (1)

Publication Number Publication Date
HUP0004627A2 true HUP0004627A2 (hu) 2001-10-28

Family

ID=25369146

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004627A HUP0004627A2 (hu) 1997-06-17 1998-06-15 Farnezil-protein transzferáz inhibitor hatású új triciklusos szulfonamidszármazékok és a vegyületeket tartalmazó gyógyszerkészítmények

Country Status (14)

Country Link
EP (1) EP0989980A1 (fr)
JP (1) JP2002507192A (fr)
KR (1) KR20010013826A (fr)
CN (1) CN1267290A (fr)
AR (1) AR012989A1 (fr)
AU (1) AU8253698A (fr)
CA (1) CA2293358C (fr)
CO (1) CO4940475A1 (fr)
HU (1) HUP0004627A2 (fr)
IL (1) IL133393A0 (fr)
NZ (1) NZ501619A (fr)
PE (1) PE86199A1 (fr)
WO (1) WO1998057949A1 (fr)
ZA (1) ZA985218B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6689789B2 (en) 1997-06-17 2004-02-10 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US7517884B2 (en) 1998-03-30 2009-04-14 Kalypsys Inc. Sulfonyl-substituted bicyclic compounds as modulators of PPAR
US7342016B2 (en) 2000-08-30 2008-03-11 Schering Corporation Farnesyl protein transferase inhibitors as antitumor agents
WO2002044164A1 (fr) * 2000-11-29 2002-06-06 Schering Corporation Nouveaux inhibiteurs de farnesyl proteine transferase
RU2384576C2 (ru) 2004-10-29 2010-03-20 Калипсис, Инк Сульфонил-замещенные бициклические соединения в качестве модуляторов ppar
KR101464767B1 (ko) 2005-10-25 2014-11-24 칼립시스, 인코포레이티드 Ppar의 조절자의 염 및 대사질환을 치료하는 방법
WO2008091863A1 (fr) 2007-01-23 2008-07-31 Kalypsys, Inc. Composés bicycliques substitués par sulfonyle utilisés comme modulateurs de ppar dans le traitement de la stéatohépatite non alcoolique
RU2015139700A (ru) * 2013-02-19 2017-03-27 Икан Скул Оф Медсин Эт Маунт Синай Трициклические гетероциклические соединения в качестве противораковых средств

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY134819A (en) * 1993-10-15 2007-12-31 Schering Corp Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
IL117798A (en) * 1995-04-07 2001-11-25 Schering Plough Corp Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them
IL117797A0 (en) * 1995-04-07 1996-08-04 Pharmacopeia Inc Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases

Also Published As

Publication number Publication date
CO4940475A1 (es) 2000-07-24
CN1267290A (zh) 2000-09-20
ZA985218B (en) 1998-12-15
WO1998057949A1 (fr) 1998-12-23
NZ501619A (en) 2002-02-01
CA2293358C (fr) 2008-08-05
IL133393A0 (en) 2001-04-30
AU8253698A (en) 1999-01-04
CA2293358A1 (fr) 1998-12-23
KR20010013826A (ko) 2001-02-26
AR012989A1 (es) 2000-11-22
PE86199A1 (es) 1999-09-24
JP2002507192A (ja) 2002-03-05
EP0989980A1 (fr) 2000-04-05

Similar Documents

Publication Publication Date Title
HUP0002954A2 (hu) Farnezil-protein transzferáz új N-szubsztituált-karbamid inhibitorai
CA2240846C (fr) Amides tricycliques destines a l'inhibition de la fonction de la proteine-g et au traitement des maladies proliferatives
HUP0000121A2 (hu) Farnezil-protein transzferáz triciklusos inhibitorai, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk
BRPI0608160A2 (pt) anticorpo isolado, célula hospedeira, método de inibir o crescimento de células psma+, e, uso de um anticorpo anti-psma defucosilado
EP0817632A1 (fr) Composes de carbamate tricyclique utilises pour inhiber la fonction proteine g et pour le traitement des maladies proliferatives
NZ274749A (en) Tricyclic carbamate derivatives useful for inhibition of g-protein function and for treating proliferative diseases, medicaments
NZ275646A (en) Tricyclic sulphonamide derivatives and medicaments
EP0927181A1 (fr) Composes tricycliques servant a inhiber la farnesyl-proteine transferase
US5925648A (en) Tricyclic N-cyanoimines useful as inhibitors of a farnesyl-protein transferase
CA2293358C (fr) Sulfonamides tricycliques servant a inhiber la farnesyl-proteine transferase
US6218401B1 (en) Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase
US6071907A (en) Tricyclic compounds useful as FPT inhibitors
US6426352B1 (en) Sulfonamide inhibitors of farnesyl-protein transferase
HUP0004521A2 (hu) Farnezil-protein transzferáz inhibitorokként alkalmazható benzo[5,6]-ciklohepta-piridil-(ciklusos karbamid- és laktám)-származékok és a vegyületeket tartalmazó gyógyszerkészítmények
EP0915869B1 (fr) Nouvelles n-cyano-imines tricycliques utiles en tant qu'inhibiteurs de la farnesyle transferase
US5945430A (en) Aminooxyamide tricyclic inhibitors of farnesyl-protein transferase
HUP0004806A2 (hu) Farnezil-protein transzferáz gátlására alkalmazható benzo [5,6]ciklohepta[1,2-b]piridin-származékok és a vegyületeket tartalmazó gyógyszerkészítmények
CA2293553C (fr) Composes tricycliques aminooxyamide inhibiteurs de farnesyl-proteine transferase
HUP0003215A2 (hu) Farnezil-protein-transzferáz új fenil-szubsztituált triciklusos inhibitorai
HUP0002863A2 (hu) Farnezil-protein transzferáz gátlására alkalmazható benzo[5,6]ciklohepta[1,2-b]piridin-származékok, és a vegyületeket tartalmazó gyógyszerkészítmények
MXPA99001110A (en) Novel tricyclic n-cyanoimines useful as inhibitors of farnesyl-protein transferase
HK1023339B (en) Novel aminooxyamide tricyclic inhibitors of farnesylprotein transferase
MXPA99012080A (en) Novel aminooxyamide tricyclic inhibitors of farnesylprotein transferase
MXPA99012079A (en) Novel phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase
MXPA99012084A (en) Novel tricyclic sulfonamide inhibitors of farnesyl-protein transferase